“aducanumab” Archives

in
Entry Author Date Location
Amgen, Novartis BACE Inhibitor Joins List of Failed Alzheimer’s Drugs 07/11/19 National
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
Biogen, Taking Its Crisis “Seriously,” Keeps Focus on Neuroscience 04/24/19 Boston
Report: Biogen, Novartis Should Drop Prices of Billon-Dollar SMA Drugs 04/04/19 Boston
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More 03/29/19 National
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More 03/22/19 National
Adieu to Adu: Biogen’s Big Alzheimer’s Bet Flops, Shares Routed 03/21/19 Boston
All Eyes on Biogen as Roche Alzheimer’s Drug Flunks Final Test 01/30/19 National
15 for ’19: Key Clinical Data to Watch for Next Year (Part 1) 12/17/18 National
Eisai & Biogen Reveal Promising Alzheimer’s Data, But Questions Linger 07/26/18 Boston
Biogen Makes Another Small Bet With Option Deal for TMS Stroke Drug 06/07/18 Boston
Biogen Pays $1B to Broaden Ionis Pact, Betting More on RNA Drugs 04/20/18 Boston
Biogen, Eisai Alzheimer’s Drug Fails First Test But Study Continues 12/21/17 Boston
Alzeca Receives $11M for Early Alzheimer’s Detection Technology 08/17/17 Texas
Biogen, Opening Bottlenecks, Sees Spine Drug Sales, Shares Rise 07/25/17 Boston
Alzheimer’s Drug Pipeline Analysis: Have We Hit Peak Amyloid? 06/21/17 National
Better Together, or Apart? Biogen, Bioverativ Head Down Separate Paths 02/01/17 Boston
Bio Roundup: NY Rises, Prez Inks Cures, Ophthotech Crashes & More 12/16/16 National
Amyloid Hypothesis Lives On—Solanezumab, Too, Despite “Siren Song” 12/09/16 Indiana
Amyloid Hypothesis Takes a Hit As Lilly’s Alzheimer’s Drug Fails Again 11/23/16 Indiana
With New Name and $47M, Proclara Begins First Big Alzheimer’s Test 09/07/16 Boston
With Biogen at a Crossroads, CEO Scangos to Step Down 07/21/16 Boston
Biogen’s Nerve Repair Drug Fails MS Study, Shares Fall 06/07/16 Boston
Ready Or Not: Next Alzheimer’s Drugs Might Strain Health Systems 04/19/16 National
Failed Alzheimer’s Drug To Get Another Shot, If Investors Pony Up 03/11/16 Boston
Biogen’s Scangos on Pricing, Deals, Hemophilia, Alzheimer’s & More 02/09/16 Boston
Biogen to Cut 400 Jobs in Massachusetts in Big Restructuring 10/21/15 Boston
East Coast Biotech Roundup: Biogen, RaNA, Inotek, Disruptors & More 07/24/15 Boston
With New Alzheimer’s Data, Biogen Refines Plans For Big Trial 07/22/15 Boston
Biogen R&D Chief Doug Williams Leaves to Run New Cancer Startup 07/10/15 Boston
Page 1 of 2 next page »